中国P站

ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tumor Suppressor Genes: Cancer Prevention and Therapeutic Targets

*Corresponding Author:

Received Date: Oct 01, 2025 / Accepted Date: Oct 29, 2025 / Published Date: Oct 29, 2025

Citation: Park DM (2025) Tumor Suppressor Genes: Cancer Prevention and Therapeutic Targets. Int J Inflam Cancer Integr Ther 12: 362.DOI: 10.4172/2381-8727.1000362

Copyright: © 2025 Dr. Min-Jae Park This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Tumor suppressor genes are vital for preventing cancer by controlling cell growth and repair. Their loss or inactivation through mutation or epigenetic silencing is common in cancer. This review discusses the roles of key tumor suppressors like RB, TP53, BRCA1/2, PTEN, and APC in cell cycle regulation, DNA repair, and signaling pathways. Genomic instability and epigenetic alterations are highlighted as significant mechanisms of their inactivation. Emerging therapeutic strategies aim to restore tumor suppressor function for cancer treatment.

International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.